Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors

被引:20
作者
Li, Zhe [1 ]
Partridge, James [1 ]
Silva-Garcia, Abel [1 ]
Rademacher, Peter [1 ]
Betz, Andreas [1 ]
Xu, Qing [1 ]
Sham, Hing [1 ]
Hu, Yunjin [2 ]
Shan, Yuqing [2 ]
Liu, Bin [2 ]
Zhang, Ying [2 ]
Shi, Haijuan [2 ]
Xu, Qiong [2 ]
Ma, Xubo [2 ]
Zhang, Li [2 ]
机构
[1] Global Blood Therapeut, San Francisco, CA 94080 USA
[2] Pharmaron Xian Co, Xian 710018, Shaanxi, Peoples R China
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2017年 / 8卷 / 02期
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Hereditary angioedema; plasma kallikrein; protease inhibitor; structure-based design; macrocycle; CONFORMATIONAL RESTRICTION; OLEFIN METATHESIS; HETEROCYCLES; TRIAL;
D O I
10.1021/acsmedchemlett.6b00384
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of macrocyclic analogues were designed and synthesized based on the cocrystal structure of small molecule plasma kallikrein (pKal) inhibitor, 2, with the pKal protease domain. This led to the discovery of a potent macrocyclic pKal inhibitor 29, with an IC50 of 2 nM for one olefinic isomer and 42.3 nM for the other olefinic isomer.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 17 条
  • [1] Prophylaxis of hereditary angioe-dema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat
    Aygoeren-Puersuen, Emel
    Magerl, Markus
    Graff, Jochen
    Martinez-Saguer, Inmaculada
    Kreuz, Wolfhart
    Longhurst, Hilary
    Nasr, Iman
    Bas, Murat
    Strassen, Ulrich
    Fang, Lei
    Cornpropst, Melanie
    Dobo, Sylvia
    Collis, Phil
    Sheridan, William P.
    Maurer, Marcus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (03) : 934 - +
  • [2] Brandl T., 2012, Patent No. [WO2012017020A1, 2012017020]
  • [3] Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234
  • [4] A phase 1 study investigating DX-2930 in healthy subjects
    Chyung, Yung
    Vince, Bradley
    Iarrobino, Ryan
    Sexton, Dan
    Kenniston, Jon
    Faucette, Ryan
    TenHoor, Chris
    Stolz, Leslie E.
    Stevens, Chris
    Biedenkapp, Joseph
    Adelman, Burt
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (04) : 460 - U271
  • [5] Cornpropst M., 2016, AAAAI ANN M MARCH 3
  • [6] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis
    El Bakali, Jamal
    Muccioli, Giulio G.
    Body-Malapel, Mathilde
    Djouina, Madjid
    Klupsch, Frederique
    Ghinet, Alina
    Barczyk, Amelie
    Renault, Nicolas
    Chavatte, Philippe
    Desreumaux, Pierre
    Lambert, Didier M.
    Millet, Regis
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (02): : 198 - 203
  • [7] SYNTHESIS OF NITROGEN-HETEROCYCLES VIA CATALYTIC RING-CLOSING METATHESIS OF DIENES
    FU, GC
    GRUBBS, RH
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (18) : 7324 - 7325
  • [8] THE APPLICATION OF CATALYTIC RING-CLOSING OLEFIN METATHESIS TO THE SYNTHESIS OF UNSATURATED OXYGEN HETEROCYCLES
    FU, GC
    GRUBBS, RH
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (13) : 5426 - 5427
  • [9] Bradykinin and the Pathogenesis of Hereditary Angioedema
    Kaplan, Allen P.
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2011, 4 : 73 - 75
  • [10] Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor
    Kobayashi, Takaaki
    Suemasa, Akihiro
    Igawa, Arisa
    Ide, Soichiro
    Fukuda, Hayato
    Abe, Hiroshi
    Arisawa, Mitsuhiro
    Minami, Masabumi
    Shuto, Satoshi
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 889 - 893